Table 3. Correlations between sTNFR1, sTNFR2, sFAS and sFASL and measures of infarct size.

		Total LGEat 5 days	Total LGEat 4 months
sTNFR1	0 h	−0.014	0.037
	24 h	0.231	0.358*
	% change	0.412*	0.385*
sTNFR2	0 h	0.005	0.034
	24 h	0.138	0.203
	% change	0.356*	0.369*
sFAS	0 h	−0.150	−0.039
	24 h	−0.304	−0.099
	% change	−0.242	−0.097
sFASL	0 h	−0.236	−0.192
	24 h	−0.210	−0.174
	% change	0.036	−0.021

Values are given as rho-values from Spearman test.

^*p<0.05.

sTNFR1, soluble tumour necrosis factor receptor 1; sTNFR2, soluble tumour necrosis factor receptor 2; sFAS, soluble FAS; sFASL, soluble FAS ligand; LGE, late gadolinium enhancement zone.